Clearer questions. More informed care.Our commercial disclosure

Reference field note

Copper tripeptide-1

A reference record with its source links, an editorial reading note, and questions to carry forward.

Aliases: GHK-Cu

Status
Topical cosmetic
Evidence label
Cosmetic-use evidence
Index topics
Skin
Status as of

The record

Recorded fields

Mechanism
A complex formed by copper and a tripeptide.
Evidence
One post-laser study found no objective between-group skin advantage.
Limitations
A topical study cannot establish the effects of an injection.
Safety
FDA identifies limited human safety data for injectable GHK-Cu.
Route context
Topical context only; not injection.
Approval scope
A skin-care ingredient; this entry is limited to topical cosmetics.

Pause and consider

A reading note

When a passage has been revised, keep the change itself available for inspection. Identify the wording that changed before deciding what the revision means. A clearer expression could preserve the earlier claim, while a changed condition could alter its scope. A newer version is therefore a place to continue reading, not a complete explanation of what happened between versions. If that history matters to your question, ask for the reason for the change and distinguish it from your own interpretation. This keeps a revision from becoming either an automatic reassurance or an automatic objection.

Questions to carry forward

  • Which wording changed, and does the change affect expression or the claim itself?
  • What explanation is offered for the revision rather than inferred from its existence?
  • Does my question concern the current passage or the reason it changed?

Follow the record

References

Prepared by the Panda Bear editorial team. Educational information; no independent medical review is claimed.